United States · FDA National Drug Code directory
HALOPERIDOL DECANOATE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70069-381_f6d888a0-65a7-4073-8671-b00b4bfaff4c
- Product NDC
- 70069-381
- Form
- INJECTION
- Composition / generic term
- HALOPERIDOL DECANOATE
- Labeler
- Somerset Therapeutics, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190404
- Source listing expiry
- 20261231
Source-listed ingredients
- HALOPERIDOL DECANOATE — 50 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (70069-381-01) / 1 mL in 1 VIAL, SINGLE-DOSE · 70069-381-01
- 10 VIAL, SINGLE-DOSE in 1 CARTON (70069-381-10) / 1 mL in 1 VIAL, SINGLE-DOSE · 70069-381-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →